Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 18:2018:1082561.
doi: 10.1155/2018/1082561. eCollection 2018.

The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats

Affiliations

The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats

Laiyuan Li et al. J Diabetes Res. .

Abstract

Purpose: To investigate the effects of sleeve gastrectomy (SG) on glucose metabolism and changes in glucagon-like peptide 1 (GLP-1) in Goto-Kakizaki (GK) rats.

Methods: GK rats were randomly assigned to one of three groups: SG, SG pair-fed plus sham surgery (PF-sham), and ad libitum-fed no surgery (control). Food intake, body weight, blood glucose, GLP-1 and insulin levels, and GLP-1 expression in the jejunum and ileum were compared.

Results: The SG rats exhibited lower postoperative food intake, body weight, and fasting glucose than did the control rats (P < 0.05). SG significantly improved glucose and insulin tolerance (P < 0.05). Plasma GLP-1 levels were higher in SG rats than in control or PF-sham rats in the oral glucose tolerance test (OGTT) (P < 0.05). Blood glucose levels expressed as a percentage of baseline were higher in SG rats than in control rats after exendin (9-39) administration (P < 0.05). The levels of GLP-1 expression in the jejunum and ileum were higher in SG rats than in PF-sham and control rats (P < 0.05).

Conclusions: Improvement of glucose metabolism by SG was associated with increased GLP-1 secretion. SG contributes to an increase in plasma GLP-1 levels via increased GLP-1 expression in the mucosa of the jejunum and/or ileum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of sleeve gastrectomy on food intake, body weight, and fasting glucose levels in GK rats. Line charts show body weights (a, b), food intake (c), and glucose (d). #P < 0.05 versus the controls; P < 0.05 versus PF-sham.
Figure 2
Figure 2
Effects of sleeve gastrectomy on glucose metabolism in GK rats. Line charts or bar graphs show the blood glucose (a), the AUCOGTT (b), insulin (c), and GLP-1 (d) in the oral glucose tolerance test, and blood glucose (e) and GLP-1 (f) after an IP injection of glucose. #P < 0.05 versus the controls; P < 0.05 versus PF-sham.
Figure 3
Figure 3
Effects of sleeve gastrectomy on insulin tolerance in GK rats. Line charts show the blood glucose (a) and the AUCITT (b) at 3 weeks, and the blood glucose (c) and the AUCITT (d) at 12 weeks after an IP injection of insulin. #P < 0.05 versus controls, P < 0.05 versus PF-sham.
Figure 4
Figure 4
Effect of exendin (9-39) on glucose metabolism in GK rats. Line charts show the blood glucose level (a) expressed as a percentage of the baseline level (b) and insulin level (c) expressed as a percentage of the baseline level (d) after an IP injection of exendin (9-39). Blood glucose levels (e) expressed as a percentage of the baseline level (f) with an IP injection of exendin (9-39), 30 min before the OGTT. #P < 0.05 versus the controls; P < 0.05 versus PF-sham.
Figure 5
Figure 5
Effects of sleeve gastrectomy on the morphology of the jejunal and ileal segments. (a) Representative images of the jejunal and ileal sections of the GK rats stained with hematoxylin-eosin are shown (magnification 100x; scale bar = 100 μm). Bar graphs show the jejunal villus length (b) and width (c) and the ileal villus length (d) and width (e). #P < 0.05 versus the controls; P < 0.05 versus PF-sham.
Figure 6
Figure 6
Effects of sleeve gastrectomy on the expression levels of the GLP-1 protein and the preproglucagon and PCSK1 genes in jejunal and ileal segments. Representative micrographs (400x magnification) of GLP-1 immunopositive cells (a) and the relative numbers of GLP-1 immunopositive cells (b, e). Expression levels of the preproglucagon (c, f) and PCSK1 genes (d, g) in the jejunum and ileum are shown. Brown GLP-1-positive staining is indicated by arrows. #P < 0.05 versus the controls; P < 0.05 versus PF-sham.

Similar articles

Cited by

References

    1. Zhou B., Lu Y., Hajifathalian K., et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet. 2016;387(10027):1513–1530. doi: 10.1016/S0140-6736(16)00618-8. - DOI - PMC - PubMed
    1. Dixon J. B., le Roux C. W., Rubino F., Zimmet P. Bariatric surgery for type 2 diabetes. The Lancet. 2012;379(9833):2300–2311. doi: 10.1016/S0140-6736(12)60401-2. - DOI - PubMed
    1. Mingrone G., Panunzi S., De Gaetano A., et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. The New England Journal of Medicine. 2012;366(17):1577–1585. doi: 10.1056/NEJMoa1200111. - DOI - PubMed
    1. Bayham B. E., Greenway F. L., Bellanger D. E., O'Neil C. E. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technology & Therapeutics. 2012;14(1):30–34. doi: 10.1089/dia.2011.0151. - DOI - PubMed
    1. Chambers A. P., Jessen L., Ryan K. K., et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141(3):950–958. doi: 10.1053/j.gastro.2011.05.050. - DOI - PMC - PubMed

LinkOut - more resources